CPA3 and COVID-19: One study verified that serum levels of carboxypeptidase A3 (CPA3) increased in patients with COVID-19, and interestingly, serotonin levels decreased in serum from SARS-CoV-19 infected patients (Soria-Castro et al., 2021).